Published • loading... • Updated
USDA Approves Merck’s INNOVAX ND-IBD-ILT
Summary by morningagclips.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
USDA Approves Merck’s INNOVAX ND-IBD-ILT
RAHWAY, N.J. — Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK), has announced U.S. Department of Agriculture approval of INNOVAX® ND-IBD-ILT, the first recombinant vaccine to provide protection against Newcastle disease, infectious bursal disease, infectious laryngotracheitis and Marek’s disease in a single hatchery vaccination. INNOVAX ND-IBD…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
